Sanofi (SNY) Other Non-Current Assets (2009 - 2026)

Sanofi has disclosed Other Non-Current Assets across 14 years of filings, most recently posting $743.4 million for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $743.4 million, down 94.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $743.4 million (down 94.85% YoY), and the FY2025 annual result was $242.1 million, down 93.96% from the prior year.
• Other Non-Current Assets came in at $743.4 million for Q1 2026 at Sanofi, up from $242.1 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $14.4 billion in Q1 2025 to a low of $161.3 million in Q3 2025.
• The 5-year median for Other Non-Current Assets is $3.5 billion (2023), against an average of $3.8 billion.
• Across the five-year window, Other Non-Current Assets advanced 29.59% in 2025 and tumbled 94.85% in 2026, its largest moves.
• Sanofi's Other Non-Current Assets stood at $3.2 billion in 2022, then grew by 9.65% to $3.5 billion in 2023, then rose by 15.83% to $4.0 billion in 2024, then slumped by 93.96% to $242.1 million in 2025, then soared by 207.05% to $743.4 million in 2026.
• The last three Other Non-Current Assets figures came in at $743.4 million (Q1 2026), $242.1 million (Q4 2025), and $161.3 million (Q3 2025), per Business Quant data.